# US 10,369,359 B2 · Device and method for single-needle in vivo electroporation > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,369,359 B2 - Document ID: US10369359B2 - Status: Granted - Kind: B2 - Application number: 11/704,591 - Filed: 2007-02-09 - Published: 2007-12-13 - Granted: 2019-08-06 - Earliest claimed: 2006-02-11 - Assignees: Genetronics, Inc. - Applicants: Rune Kjeken; Iacob Mathiesen; Elisabeth Torunn Tjelle; George McHugh - Inventors: Rune Kjeken; Iacob Mathiesen; Elisabeth Torunn Tjelle; George McHugh - Web page: https://patentgrep.com/patent/US10369359B2 ## CPC - A61N 1/327: {for enhancing the absorption properties of tissue, e.g. by electroporation} - A61N 1/30: Apparatus for iontophoresis, {i.e. transfer of media in ionic state by an electromotoric force into the body}, or cataphoresis - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) ## Abstract Described is a device and method for administration of molecules to tissue in vivo for various medical applications, the device comprising a single hypodermic injection needle and at least two spaced elongate electrodes which provide for the ability, when the needle is inserted into tissue, such as skin or muscle, to pulse tissue with a non-uniform electric field sufficient to cause reversible poration of cells lying along or in close proximity to the track made by the needle upon its insertion into said tissue. ## Claims ### Claim 1 A device for electroporation of tissue in vivo for delivering therapeutic substances into cells of a tissue comprising: a single electroporating needle having a tissue-piercing tip, said needle comprising: a shaft that is elongated, hollow, and adapted for delivery of a fluid comprising a therapeutic substance to said tissue, said shaft having a length running from one end of the needle to the tip of the needle at an other end of the needle, and at least two electrodes exposed along an outer surface of said shaft that are adapted to produce a generally cylindrical electric field, said at least two electrodes spaced and electrically isolated from one another and situated spiraling and parallel to one another along the length of said shaft; an electrical energy source; and electric conduits capable of connecting each of said at least two electrodes to the electrical energy source, wherein when said shaft is inserted into said tissue and said at least two electrodes are energized by said electrical energy source, said at least two electrodes are in contact with said tissue and are capable of generating the generally cylindrical electric field in a treatment zone surrounding the length of said shaft, wherein the at least two electrodes are configured to transmit electric pulses from the electrical energy source that have a current in a range of 1 mAmp to 400 mAmp so as to cause cells in said treatment zone to become reversibly porated so as to allow said cells to take up said therapeutic substance. ### Claim 2 (depends on 1) The device according to claim 1 further comprising a reservoir having an adjustable volume in fluid communication with said shaft. ### Claim 3 (depends on 2) The device according to claim 2 wherein said reservoir comprises a syringe. ### Claim 4 (depends on 3) The device according to claim 3 wherein said reservoir has a variable volume capacity selected from the group consisting of 0.0 ml to 0.5 ml, 0.0 ml to 1 ml, 0.0 ml to 3 ml, and 0.0 ml to 5 ml. ### Claim 5 (depends on 1) The device according to claim 1 wherein said electrical energy source is an electroporation pulse generator. ### Claim 6 (depends on 5) The device according to claim 5 wherein said electroporation pulse generator is capable of generating the electric pulses, wherein the electric pulses have an average voltage in a range between 1 V to 200 V. ### Claim 7 (depends on 5) The device according to claim 5 wherein said electroporation pulse generator is capable of generating the electric pulses having a time length selected from the group consisting of 0.1 μs to 1000 ms. ### Claim 8 (depends on 5) The device according to claim 5 wherein the at least two electrodes have a total surface area configured to deliver the electric pulses that have the current in a range of 5 mAmps to 200 mAmps to reversibly porate cells in the treatment zone. ### Claim 9 (depends on 8) The device according to claim 8 wherein said current is within a range between 25 mAmps and 100 mAmps. ### Claim 10 (depends on 5) The device according to claim 5 wherein said electroporation pulse generator is capable of generating the electric pulses having a frequency selected from the group consisting of 1 Hz to 10,000 Hz. ### Claim 11 (depends on 1) The device according to claim 1 wherein said shaft is a hypodermic needle sized to a gauge of an injection needle selected from the group consisting of 20 gauge, 21, gauge, 22 gauge, 23 gauge, 24 gauge, 25 gauge, 25 gauge, 26 gauge, 27 gauge, 28 gauge and 29 gauge. ### Claim 12 (depends on 1) The device according to claim 1 wherein said shaft is electrically insulated from each of the at least two electrodes. ### Claim 13 (depends on 1) The device according to claim 1 wherein said tissue comprises any tissue type or organ selected from the group consisting of skin, subcutaneous tissue, intradermal tissue, subdermal tissue, skeletal muscle, striated muscle, smooth muscle, organs, heart, breast, lung, pancreas, liver, spleen and mucosa. ### Claim 14 (depends on 1) The device according to claim 1, wherein the at least two electrodes each run an entire length of said shaft.